封面
市场调查报告书
商品编码
1746891

日本家庭输液治疗市场报告(按产品、应用和地区)2025-2033

Japan Home Infusion Therapy Market Report by Product, Application, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年,日本家庭输液治疗市场规模达26.85亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到47.823亿美元,2025-2033年期间的复合年增长率(CAGR)为6.6%。慢性病发病率的上升、家庭医疗保健需求的日益增长以及产品供应的持续改进是推动市场成长的主要因素。

居家输液疗法是一种专业的医疗手段,利用帮浦、导管和药瓶等各种设备,在患者舒适的家中,透过静脉注射方式为其输送药物(例如抗病毒药物或免疫球蛋白)、液体或营养物质。这种疗法适用于感染、癌症或患有多发性硬化症 (MS) 或类风湿性关节炎等慢性疾病且需要长期或频繁输液治疗的患者。居家输液疗法带来舒适便捷的体验,提高病患的整体生活品质,并降低医院内感染的风险。此外,它还能增强患者的能力,让他们在接受必要的医疗照护的同时,保持独立性和对自身治疗的掌控感。居家输液疗法在多种治疗中都特别有效,包括化疗、补液、肠内给药、正性肌力治疗、抗感染治疗、营养治疗和疼痛管理等,常用于治疗糖尿病以及各种胃肠道疾病和肿瘤疾病。

日本家庭输液治疗市场趋势:

日本家庭输液治疗市场正经历大幅成长,这得益于癌症、骨关节炎、人类免疫缺陷病毒 (HIV) 和糖尿病等慢性疾病盛行率的上升。老年人口的不断增长,更容易患上需要定期就医的危及生命的疾病,尤其是输液治疗,这也对市场成长做出了重大贡献。此外,政府措施、优惠的报销政策以及长期住院带来的医疗费用上涨,都在激励患者选择家庭输液治疗,进一步推动了市场扩张。此外,由于家庭医疗保健服务便利且经济高效,人们越来越倾向于选择此类服务,再加上医院资源日益紧张,也是另一个重要的成长诱因。此外,由于长期接触受污染的设备、床单和空气飞沫,医院内获得性感染 (HAI) 的增加也加剧了市场的扩张。对专科药物的广泛需求以及对专科用药的需求,也为市场带来了新的成长动力。此外,预计创新技术进步将在预测期内推动市场成长,例如开发配备先进滴灌系统的轻巧、便携、用户友好的输液泵,用于精确即时监测静脉注射治疗。

日本家庭输液治疗市场区隔:

产品洞察:

  • 点滴帮浦
    • 弹性体
    • 机电
    • 重力
    • 其他的
  • 静脉输液器
  • 静脉插管
  • 无针头连接器

应用程式洞察:

  • 抗感染
  • 内分泌学
    • 糖尿病
    • 其他的
  • 水合疗法
    • 运动员
    • 其他的
  • 化疗
  • 肠内营养
  • 肠外营养
  • 特种製药
  • 其他的

竞争格局:

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。

本报告回答的关键问题:

  • 日本家庭输液治疗市场迄今表现如何?未来几年将如何表现?
  • COVID-19 对日本家庭输液治疗市场有何影响?
  • 日本家庭输液治疗市场依产品划分是怎样的?
  • 日本家庭输液治疗市场如何根据应用情况划分?
  • 日本家庭输液治疗市场的价值链分为哪些阶段?
  • 日本家庭输液治疗的主要驱动因素和挑战是什么?
  • 日本家庭输液治疗市场的结构是怎么样的?主要参与者是谁?
  • 日本家庭输液治疗市场的竞争程度如何?

本报告回答的关键问题:

  • 日本家庭输液治疗市场迄今表现如何?未来几年将如何表现?
  • COVID-19 对日本家庭输液治疗市场有何影响?
  • 日本家庭输液治疗市场依产品划分是怎样的?
  • 日本家庭输液治疗市场如何根据应用情况划分?
  • 日本家庭输液治疗市场的价值链分为哪些阶段?
  • 日本家庭输液治疗的主要驱动因素和挑战是什么?
  • 日本家庭输液治疗市场的结构是怎么样的?主要参与者是谁?
  • 日本家庭输液治疗市场的竞争程度如何?

目录

第一章:前言

第二章:范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:日本家庭输液治疗市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章:日本家庭输液治疗市场格局

  • 历史与当前市场趋势(2019-2024)
  • 市场预测(2025-2033)

第六章:日本家庭输液治疗市场-细分:依产品

  • 点滴帮浦
    • 概述
    • 市场区隔
      • 弹性体
      • 机电
      • 重力
      • 其他的
  • 静脉输液器
    • 概述
  • 静脉插管
    • 概述
  • 无针头连接器
    • 概述

第七章:日本家庭输液治疗市场-细分:依应用

  • 抗感染
    • 概述
  • 内分泌学
    • 概述
    • 市场区隔
      • 糖尿病
      • 其他的
  • 水合疗法
    • 概述
    • 市场区隔
      • 运动员
      • 其他的
  • 化疗
    • 概述
  • 肠内营养
    • 概述
  • 肠外营养
    • 概述
  • 特种製药
    • 概述
  • 其他的

第 8 章:日本家庭输液治疗市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第九章:关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 10 章:日本家庭输液治疗市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 11 章:附录

简介目录
Product Code: SR112025A19967

Japan home infusion therapy market size reached USD 2,685.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,782.3 Million by 2033, exhibiting a growth rate (CAGR) of 6.6% during 2025-2033. The growing incidence of chronic illnesses, the rising inclination towards home healthcare, and continuous advancements in product offerings are among the primary factors propelling the market growth.

Home infusion therapy is a specialized medical treatment that involves delivering medications, such as antivirals or immune globulin, fluids, or nutrition intravenously to patients in the comfort of their homes, utilizing various equipment like pumps, catheters, and vials. This form of therapy is recommended for individuals dealing with infections, cancer, or chronic conditions like multiple sclerosis (MS) or rheumatoid arthritis that necessitate long-term or frequent infusion treatment. Home infusion therapy provides a sense of comfort and convenience, enhances the overall quality of life, and diminishes the risk of hospital-acquired infections. Moreover, it empowers patients by allowing them to maintain a sense of independence and control over their treatment while still receiving essential medical care. Home infusion therapy is particularly effective in diverse treatments, including chemotherapy, hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies, commonly employed for conditions such as diabetes and various gastrointestinal and oncological disorders.

Japan Home Infusion Therapy Market Trends:

The Japan home infusion therapy market is witnessing substantial growth, driven by an increase in the prevalence of chronic diseases like cancer, osteoarthritis, human immunodeficiency viruses (HIV), and diabetes. The expanding geriatric population, more susceptible to life-threatening illnesses requiring regular medical attention, particularly infusion therapy, is also contributing significantly to market growth. Besides this, government initiatives, favorable reimbursement policies, and the rising costs associated with prolonged hospital stays are motivating patients to opt for home infusion therapy, further fueling market expansion. Additionally, the growing preference for home healthcare services due to their convenience and cost-effectiveness, coupled with the increasing strain on hospital resources, is acting as another significant growth-inducing factor. Apart from this, the rise in hospital-acquired infections (HAIs) due to prolonged exposure to contaminated equipment, bed linens, and air droplets is amplifying the market's expansion. The widespread demand for specialty drugs, necessitating specialized administration, adds another layer of growth to the market. Furthermore, innovative technological advancements, such as the development of lightweight, portable, and user-friendly infusion pumps equipped with advanced drip systems for precise and real-time monitoring of IV treatments, are anticipated to fuel the market growth over the forecasted period.

Japan Home Infusion Therapy Market Segmentation:

Product Insights:

  • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Application Insights:

  • Anti-Infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan home infusion therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan home infusion therapy market?
  • What is the breakup of the Japan home infusion therapy market on the basis of product?
  • What is the breakup of the Japan home infusion therapy market on the basis of application?
  • What are the various stages in the value chain of the Japan home infusion therapy market?
  • What are the key driving factors and challenges in the Japan home infusion therapy?
  • What is the structure of the Japan home infusion therapy market and who are the key players?
  • What is the degree of competition in the Japan home infusion therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Home Infusion Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Home Infusion Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Home Infusion Therapy Market - Breakup by Product

  • 6.1 Infusion Pumps
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Elastomeric
      • 6.1.3.2 Electromechanical
      • 6.1.3.3 Gravity
      • 6.1.3.4 Others
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Intravenous Sets
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 IV Cannulas
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Needleless Connectors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)

7 Japan Home Infusion Therapy Market - Breakup by Application

  • 7.1 Anti-Infective
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Endocrinology
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Diabetes
      • 7.2.3.2 Others
    • 7.2.4 Market Forecast (2025-2033)
  • 7.3 Hydration Therapy
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Segmentation
      • 7.3.3.1 Athletes
      • 7.3.3.2 Others
    • 7.3.4 Market Forecast (2025-2033)
  • 7.4 Chemotherapy
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Enteral Nutrition
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Parenteral Nutrition
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2019-2024)
    • 7.6.3 Market Forecast (2025-2033)
  • 7.7 Specialty Pharmaceuticals
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2019-2024)
    • 7.7.3 Market Forecast (2025-2033)
  • 7.8 Others
    • 7.8.1 Historical and Current Market Trends (2019-2024)
    • 7.8.2 Market Forecast (2025-2033)

8 Japan Home Infusion Therapy Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Company A
    • 9.1.1 Business Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Company B
    • 9.2.1 Business Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Company C
    • 9.3.1 Business Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Company D
    • 9.4.1 Business Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Company E
    • 9.5.1 Business Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events

10 Japan Home Infusion Therapy Market - Industry Analysis

  • 10.1 Drivers, Restraints, and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix